| Market Capitalization (Millions $) |
941 |
| Shares
Outstanding (Millions) |
665 |
| Employees |
3,930 |
| Revenues (TTM) (Millions $) |
713 |
| Net Income (TTM) (Millions $) |
-53 |
| Cash Flow (TTM) (Millions $) |
350 |
| Capital Exp. (TTM) (Millions $) |
25 |
Opko Health Inc
Opko Health Inc is a multi-billion dollar healthcare provider that specializes in diagnostic and pharmaceutical products, especially those related to genetic testing, diagnostics and medical devices along with pharmaceuticals. Founded by Dr. Phillip Frost in 1991, the company is headquartered in Miami, Florida and has a global presence across North America, Europe, Asia and South America. The company has a diverse portfolio of products and services with emphasis on precision medicine and personalized healthcare.
Opko Health has three main divisions e pharmaceuticals, diagnostics and laboratory services. They provide genomic testing and analysis to detect and treat various diseases such as cancer, hepatitis, cardiovascular diseases, endocrinology and infectious diseases. The company's diagnostics division produces a wide range of products, including genetic and infectious disease tests and imaging services. They have also developed a Point-of-Care (POC) testing device for COVID-19, which can be used at clinics, hospitals and testing centers.
The company's pharmaceutical division develops and commercializes products for various diseases such as chronic kidney disease, growth hormone deficiency, vitamin D deficiency and prostate cancer. OPKO Biologics is the subsidiary of the company which produces a range of products based on innovative technology such as RNA interference (RNAi) and gene therapy.
Opko Health also provides laboratory services to medical providers, hospitals and clinics across the world with their subsidiary BioReference Laboratories. The laboratory services include molecular diagnostics, genomic testing and pathology services. It has been recognized for quality and performance with clinical excellence awards from various medical organizations.
Opko Health has a strong pipeline of products with a focus on precision medicine and personalized healthcare. It has both in-house R&D and collaborations with other pharmaceutical companies to develop new treatment and diagnostic products that meet patient needs. The company has also received several approvals from the US Food and Drug Administration (FDA) for its products and devices.
In conclusion, Opko Health Inc is a major healthcare provider with an extensive range of products and services, and a strong focus on innovation, precision medicine and personalized healthcare. It has a global presence and is dedicated to improving patient outcomes and creating value for shareholders.
Company Address: 4400 Biscayne Blvd. Miami 33137 FL
Company Phone Number: 575-4100 Stock Exchange / Ticker: NASDAQ OPK
|
3.78% 
69.84 %